Aurinia Pharmaceuticals (AUPH) Tax Provisions (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) reported Tax Provisions of $9.6 million for Q1 2026, up 857.0% on a YoY basis from $1.0 million in Q1 2025, and up 105.47% quarter-over-quarter from -$175.1 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Tax Provisions (2020 - 2026) Analysis & Trends
Aurinia Pharmaceuticals has reported Tax Provisions for 7 years, with the latest figure at $9.6 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions rose 857.0% year-over-year to $9.6 million; the trailing twelve-month figure through Mar 2026 stood at -$164.4 million (down 8523.92% YoY), and the FY2025 full-year result was -$173.0 million, down 10300.47% from the prior year.
- Tax Provisions for Q1 2026 stood at $9.6 million, up from -$175.1 million in the prior quarter.
- The five-year high for Tax Provisions was $9.6 million in Q1 2026, with the low at -$175.1 million in Q4 2025.
- Historically, Tax Provisions has averaged -$9.4 million across 5 years, with a median of $451000.0 in 2023.
- Annual changes were most pronounced in 2022 — Tax Provisions soared 11825.0% — and 2025, when it plunged 57485.2%.
- Aurinia Pharmaceuticals' Tax Provisions stood at $827000.0 in 2022, then slumped by 45.47% to $451000.0 in 2023, then slumped by 167.41% to -$304000.0 in 2024, then sank by 57485.2% to -$175.1 million in 2025, then jumped by 105.47% to $9.6 million in 2026.
- The last three Tax Provisions figures came in at $9.6 million (Q1 2026), -$175.1 million (Q4 2025), and $411000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aurinia Pharmaceuticals | 2.18 Bn | 1.80 Bn | 71.20 Mn | 9.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.57 Mn |
| Dec 31, 2025 | -175.06 Mn |
| Sep 30, 2025 | 411,000.00 |
| Jun 30, 2025 | 643,000.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | -304,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 756,000.00 |
| Mar 31, 2024 | 739,000.00 |
| Dec 31, 2023 | 451,000.00 |
| Sep 30, 2023 | 298,000.00 |
| Jun 30, 2023 | -600,000.00 |
| Mar 31, 2023 | 436,000.00 |
| Dec 31, 2022 | 827,000.00 |
| Sep 30, 2022 | 954,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 726,000.00 |
| Sep 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 18,000.00 |